搜尋結果
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
CNBC· 4 小時前The drugmaker now expects full-year adjusted earnings of $13.50 to $14.00 per share, up from a previous guidance of $12.20 ...
Siemens Smart Infrastructure BrandVoice: Smart Hospitals: Digitalizing Healthcare For A New Era
Forbes· 10 小時前There are very few places in the world that elicit the same reaction from the majority of ...
U.K. Government Accused Of Scapegoating Disabled In Proposed Welfare Cuts
Forbes· 10 小時前Several U.K. charities representing the interests of disabled people have lambasted the government in response to proposed ...